Board of Directors

Claes Post

Claes Post

Pharm Dr, Professor

Claes Post has a Master of Pharmacy from Uppsala University, Pharm Dr from Linköping University, Associate Professor in Neuropharmacology and Anaesthesiology from Uppsala University, Professor (Adjunct) in Neuropharmacology at Linköping University. Between 1981 and 1994 he was Preclinical Vice President at Astra Pain Control and Astra Draco, then between 1994 and 1997 he was Senior Vice President Preclinical and Clinical CNS Drug Discovery and Development, as well as Medical Director CNS at Pharmacia in Milan, Italy. He has been CEO of several start-up companies in the pharmaceutical fields, been engaged in university-based technology transfer, and Investment Manager at ALMI INVEST AB. He is a Board member of four Life science companies. Claes has published more than 140 articles in peer-review scientific journals and has been mentor and supervisor of MD and PhD students.

Board member since 2017.

Holdings in AroCell: 50 000 shares
Warrants in AroCell: 100 000.

Independent in relation to the company and its management and in relation to major shareholders.

Eva Nordström

Eva Nordström

Ph.D.

Eva has a Ph.D. in immunology under Prof. Erna Möller at Stockholm University and is currently working as a Senior Researcher at BioArctic AB. She has wide scientific experience from assay development, hybridoma generation and immunoassays.

Board member since 2020

Holdings in AroCell: 7 079 shares.

Independent in relation to the company and its management and in relation to major shareholders.

Agneta Franksson

Agneta Franksson

MBA, M.Sc.

Agneta Franksson holds an MBA from Uppsala University and a Master of Science degree from the Royal institute of Technology in Stockholm. Agneta has experience from two CEO positions, Vita Nova Ventures AB (Publ) (a CRO company) and Falck Ambulans AB (healthcare services) and more than 25 years’ experience from research, clinical trials, product/service development, and international sales and marketing.

Since 2006 she has run her own management consulting firm focusing on analytic work, developing road maps, strategic plans, project managements, brand, profile, value work, and implementation of market access strategies. Agneta has served on several boards during the last 12 years. Today she is a member of the board of Blekinge Institute of Technology and serves as the Chairman of the Board of Directors of Specialplast Wensbo AB and HoofStep AB. She received the national prize “Supergasell 2016” (Dagens Industri).

Board member since 2017

Holdings in AroCell: Nil shares

Independent in relation to the company and its management and in relation to major shareholders.

Karin Eriksson-Widblom

Karin Eriksson-Widblom

M Sc

Karin Eriksson-Widblom has worked as a Sales and Marketing Director at Fujirebio Diagnostics AB for several years and has held several other positions at, among others, EniChem and Nolato Medical. Karin has therefore extensive experience in marketing and sales of biomarkers focused on oncology.

Board member since 2019

Warrants in AroCell: 100 000.

Independent in relation to the company and its management and in relation to major shareholders.